Clinical Trial Update: Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals [Phase 2]

View source ↗

Summary

This entry outlines a Phase 2 clinical trial evaluating remdesivir for upper respiratory tract infection due to respiratory syncytial virus in immunocompromised…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Disease
• Hematologic Malignancy
• Respiratory Syncytial Virus Infection

Drugs mentioned

• Remdesivir (remdesivir)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Hematopoietic and Lymphatic System Neoplasm, Autoimmune Disease | Phase 2 | Status: RECRUITING